Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Challenges presented by nerve damage in leprosy.

Morten Harboe1, Abraham Aseffa, Ruth Leekassa

  • 1Institute of Immunology, University of Oslo, Rikshospitalet, Norway. morten.harboe@labmed.uio.no

Leprosy Review
|May 11, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Decision-making for indoor residual spraying in the post-elimination phase of visceral leishmaniasis in Nepal.

PLoS neglected tropical diseases·2026
Same author

Genomic characterization of <i>Klebsiella pneumoniae</i> isolates from sepsis patients in Ethiopian tertiary hospitals: a multicenter cross-sectional study.

Frontiers in microbiology·2026
Same author

Mapping the last mile: Micro-stratification for sustained visceral leishmaniasis elimination in Bangladesh.

PLoS neglected tropical diseases·2026
Same author

Visceral leishmaniasis & HIV co-infection in Bangladesh: Investigating prevalence and policy recommendations.

Journal of infection and public health·2026
Same author

Maternal infection at delivery and risk of stillbirth and early neonatal death: nested case-control studies in East African pregnancy cohorts.

BMC pregnancy and childbirth·2026
Same author

Rapid Ethical Appraisal: A tool to design a contextualized consent process for a genetic study of podoconiosis in Ethiopia.

Wellcome open research·2026

Leprosy nerve damage stems from Mycobacterium leprae invading Schwann cells. Immune responses to M. leprae antigens cause bystander nerve injury, necessitating combined immunosuppressive and anti-mycobacterial therapies.

Area of Science:

  • Immunology
  • Neuroscience
  • Infectious Diseases

Background:

  • Leprosy nerve damage is primarily caused by Mycobacterium leprae invasion of Schwann cells.
  • The interaction involves alpha-Dystroglycan on Schwann cells binding to laminin alpha2 and M. leprae surface receptors.
  • Nerve damage during reversal reactions is linked to heightened delayed-type hypersensitivity against M. leprae antigens.

Purpose of the Study:

  • To elucidate the mechanisms of nerve damage in leprosy.
  • To understand the role of immune responses in leprosy-associated neuropathy.
  • To highlight challenges in leprosy control despite advances in multidrug therapy.

Main Methods:

  • Review of existing literature on leprosy pathogenesis and immunology.
  • Analysis of the molecular interactions between M. leprae and Schwann cells.

Related Experiment Videos

  • Investigation of immune-mediated mechanisms contributing to nerve damage.

    • Main Results:

    • Mycobacterium leprae invades Schwann cells, initiating nerve damage.
    • Immune responses, including CD4+ T cell lysis and Toll-like receptor activation, contribute to nerve injury.
    • Persistence of M. leprae antigens post-multidrug therapy is a risk factor for late reactions.

    Conclusions:

    • Nerve damage in leprosy is a complex process involving direct bacterial effects and immune-mediated bystander injury.
    • Current multidrug therapy (MDT) reduces prevalence but does not eliminate the challenge of controlling nerve damage.
    • Early diagnosis and effective treatment of nerve damage remain critical for leprosy control.